Effects of isatin, an endogenous MAO inhibitor, on dopamine (DA) and acetylcholine (ACh) concentrations in rats

Folia Pharmacologica Japonica

Volumn 114, Issue SUPPL. 1, 1999, Pages 186-191

  Minami, Masaru ^a   Hamaue, Naoya ^a   Endo, Toru ^a   Hirafuji, Masahiko ^a   Terado, Mutsuko ^a   Ide, Hajime ^a   Yamazaki, Noriko ^b   Yoshioka, Mitsuhiro ^b   Ogata, Akihiko ^b   Tashiro, Kunio ^b  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Acetylcholine; Dopamine; Isatin; Parkinson's rat model; Striatum

Indexed keywords

ACETYLCHOLINE; DOPAMINE; ISATIN; MONOAMINE OXIDASE INHIBITOR;

ACETYLCHOLINE BRAIN LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DRUG EFFECT; DRUG URINE LEVEL; INTRAPERITONEAL DRUG ADMINISTRATION; MENTAL STRESS; NONHUMAN; PARKINSON DISEASE; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 13044312094     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.114.supplement_186     Document Type: Article

References (20)

1. Glover V, Reveley MA and Sandier M: A monoamine oxidase inhibitor in human urine. Biochem. Pharmacol. 29, 467-470 (1980)
2. Elsworth JD, Dewar D, Glover V, Goodwin BL, Clow A and Sandier M: Purification and characterization of tribulin, an endogenous inhibitor of monoamine oxidase and benzodiazepine receptor binding. J. Neural. Transm. 67, 45-56 (1986)
3. Glover V, Halket JM, Watkins PJ, Clow A, Goodwin BL and Sandier M: Isatin: Identity with the purified endogenous monoamine oxidase inhibitor tribulin. J. Neurochem. 51, 656-659 (1988)
4. Hamaue N, Minami M, Kanamaru Y, Togashi M, Monma Y, Ishikura M, Mahara R, Yamazaki N, Togashi H, Saito H and Parvez SH: Endogenous monoamine oxidase (MAO) inhibitor (tribulin-like activity) in the brain and urine of stroke-prone SHR. Biog. Amines 8, 401-412 (1992)
5. Hamaue N, Minami M, Kanamaru Y, Ishikura M, Yamazaki N, Saito H and Parvez SH: Identification of isatin, an endogenous MAO inhibitor, in the brain of stroke-prone SHR. Biog. Amines 10, 99-110 (1994)
6. Glover V, Clow A and Sandier M: Effects of dopaminergic drugs on superoxide dismutase: implications for senescence. J. Neurol. Transm. 40 (Suppl), 37-45 (1993)
7. Medvedev AE, Clow A, Sandier M and Glover V: Isatin: A link between natriuretic peptides and monoamines? Biochem. Pharmacol. 52, 385-391 (1996)
8. Chocholova L and Kolinova M: Effect of isatin (2, 3 dioxyindoline) on physiological and pathological electrographic manifestations of vigilance. Physiol. Bohemoslov. 30, 129-137 (1981)
9. Chocholova L and Kolinova M: Effect of isatin on audiogenic seizures in rats and its relationship to electrographic and behavioral phenomena. Physiol. Bohemoslov. 28, 495-502 (1979)
10. Clow A, Hussain T, Glover V, Sandier M, Walker M and Dexter D: Pergolide can induce soluble superoxide dismutase in rat striata. J. Neural. Transm. 90, 27-31 (1992)
11. Hamaue N, Minami M, Hirafuji M, Monma Y, Yamazaki N, Togashi H, Saito H and Parvez SH: Significance of isatin, an endogenous MAO inhibitor, on blood pressure control and monoamine levels. Biog. Amines 12, 395-405 (1996)
12. Hamaue N, Yamazaki N, Minami M, Endo T, Hirafuji M, Monma Y, Togashi H, Saito H and Parvez SH: Effects of isatin, an endogenous MAO inhibitor, on acetylcholine and dopamine levels in the rat striatum. Biog. Amines 15, 367-377 (1999)
13. Hamaue N, Yamazaki N, Minami M, Endo T, Hirafuji M, Monma Y and Togashi H: Determination of isatin, an endogenous monoamine oxidase inhibitor, in urine and tissues of rats by HPLC. Gen. Pharmacol. 30, 387-391 (1998)
14. Hoehn MM and Yarh MD: Parkinsonism: onset, progression and mortality. Neurolol. 17, 427-442 (1967)
15. Ogata A, Tashiro K, Nukuzuma S, Nagashima K and Hall WW: A rat model of Parkinson's disease induced by Japanese encephalitis virus. J. Neurovirol. 3, 141-147 (1997)
16. Ogawa N, Hirose Y, Ohara S, Ono T and Watanabe Y: A simple quantitative bradylinesia test in MPTP-treated mice. Res. Comm. Chem. Pathol. Pharmacol. 50(3), 435-441 (1985)
17. Tozawa Y, Ueki A, Manabe S and Matsushima K: Stress-induced increase in urinary isatin excretion in ratsreversal by both dexamethasone and a-methyl-p-tyrosine. Biochem. Pharmacol. 56, 1041-1046 (1998)
18. Battacharya SK, Chakrabarti A, Sandier M and Glover V: Anxyolytic activity of intraventricularly administered atrial natriuretic peptide in the rat. Neuropsychopharmacol. 15, 199-206 (1996)
19. Glover V, Medvedev A and Sandier M: Isatin is a potent endogenous antagonist of guanylate cyclase-coupled atrial natriuretic peptide receptors. Life Sci. 57, 2073-2079 (1995)
20. Kumar P, Bansal RC and Mahmood A: Isatin, an inhibitor of acetylcholinesterase activity in rat brain. Biog. Amines 9, 281-289 (1993)